National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1418691

Case Details

VAERS ID: 1418691 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Abdominal distension, Cold sweat, Dizziness, Fatigue, Feeling hot, Headache, Maternal exposure during pregnancy, Nausea, Palpitations
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Suspected COVID-19
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021663652

Write-up: Headache; Clammy; Bloating; Feeling hot; Nausea; Heart racing; Tiredness; Dizziness/Felt faint; Maternal exposure during pregnancy/Patient was exposed to the medicine second-trimester (13-28 weeks); This is a spontaneous report from a contactable consumer received from a regulatory authority. The regulatory authority report number is GB-MHRA-APPCOVID-202106060922142550-AIHYG. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 04Jun2021 (at the age of 32-year-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included suspected COVID-19 from 21Mar2020 to 10Apr2020 and was not ongoing. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. Concomitant medication included aspirin [acetylsalicylic acid] taken for pregnancy from 01Mar2021; folic acid taken for vitamin supplementation. On 04Jun2021, the patient experienced maternal exposure during pregnancy/patient was exposed to the medicine second-trimester (13-28 weeks), dizziness/felt faint, and tiredness. On 05Jun2021, the patient experienced nausea, heart racing, headache, clammy, bloating, and feeling hot. The events were medically significant. Patient has not tested positive for COVID-19 since having the vaccine. Outcome of the headache was recovered on 05Jun2021, of the dizziness/felt faint and feeling hot was recovered on 06Jun2021, of the nausea, heart racing, tiredness, and clammy was recovering, and of the bloating was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166